🔎 Trials Near Me

Akèy › Glomeruloskleroz fokal segmantè › Illinois › Chicago

Etid klinik pou Glomeruloskleroz fokal segmantè nan Chicago, IL

4 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Ap rekriteFaz 3
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • Northwestern University, Chicago
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Ap rekriteFaz 2
  • Northwestern Memorial Hospital- Site Number : 8400014, Chicago
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702

NEPTUNE Match Study

Ap rekrite
  • John H. Stroger, Jr., Hospital of Cook County, Chicago
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658

Nephrotic Syndrome Study Network

Ap rekriteEtid obsèvasyon
  • John Stroger Cook County Hospital, Chicago
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000

Etid Glomeruloskleroz fokal segmantè nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.